Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Aims Dual-coil implantable cardioverter defibrillator (ICD) leads have traditionally been used
over single-coil leads due to concerns regarding high defibrillation thresholds (DFT) and …

Recently, polarity-dependent shock failures were reported in implantable cardioverter-
defibrillators caused by structural failure in the high-voltage feedthrough. Short circuits may …

Abstract Background In 2022 and 2023, Medtronic recalled implantable defibrillators
because they may deliver less than full-energy shocks. The 2022 problem truncates the …

Abstract Purpose of Review In the current era of implantable cardioverter-defibrillator
procedures, the decision of whether or not to perform defibrillation threshold testing at the …

The implantable cardioverter-defibrillator (ICD) is the best therapeutic option to prevent
sudden cardiac death for several high-risk groups of patients. Basically, the ICD can …

O cardioversor-desfibrilador implantável (CDI) é a melhor opção terapêutica para prevenir a
morte súbita cardíaca para vários grupos de pacientes de alto risco. Basicamente, o CDI …

Abstract Purpose Implantable cardioverter defibrillators (ICDs) can treat life-threatening
tachyarrhythmia with high-voltage shocks. The aims were to compare the efficacy of single …

Implantable cardioverter defibrillator (ICD) remains the mainstay therapy for patients at risk
of malignant arrhythmias and sudden cardiac death (SCD). 1, 2 This is achieved by the …